Julie Johnson sold JPMorgan Chase & Co (NYSE: JPM)
Julie Johnson (D-TX), a U.S. Representative, has disclosed 1 trade in JPMorgan Chase & Co (JPM) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Julie Johnson sold $1,001 - $15,000 of JPMorgan Chase & Co (NYSE: JPM) on April 7, 2025. Since that trade, JPM is up +63.87% against the S&P 500 up +46.29%, an outperformance of +17.59%.
Data updated
Julie Johnson's JPM trades vs the price
JPM is up +63.87% since Julie Johnson sold on April 7, 2025, versus +46.29% for the S&P 500.
Performance since this trade
All Julie Johnson JPM trades
Julie Johnson & JPM trading FAQ
Is it legal for Julie Johnson to trade JPMorgan Chase & Co (JPM) stock?
Yes. Members of Congress are allowed to trade individual stocks, including JPMorgan Chase & Co (JPM), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Julie Johnson sell JPM?
Julie Johnson disclosed a sale of $1,001 - $15,000 of JPMorgan Chase & Co (JPM) on April 7, 2025, according to public STOCK Act filings.
How has JPM performed since Julie Johnson's trade?
Since Julie Johnson sold JPM on April 7, 2025, the stock is up +63.87%, versus +46.29% for the S&P 500 over the same period, an outperformance of +17.59%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional JPM trades?
Quantellect tracks every disclosed congressional trade in JPMorgan Chase & Co (JPM) on the JPMorgan Chase & Co congressional trading page, which aggregates filings across all members of Congress.
Julie Johnson's JPM tradesAll congressional filings for JPMorgan Chase & CoJulie Johnson's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.